Source: ERS webinar 2020: COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Venerino Poletti (Forli, Italy), Katerina Antoniou (Heraklion, Greece), Elizabeth Renzoni (London, United Kingdom), Sara Tomassetti (Forli, Italy), Athol Wells (London, United Kingdom), Sergio Harari (Milan, Italy), Giorgina Dalpiaz (Bologna, Italy), Bruno Crestani (Paris, France). COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations. ERS webinar 2020: COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations

Member's Comments

Husam Abou Jokh - 15.07.2020 14:38
excellent presentations

Md. Ashad Hussain Arafat - 23.06.2020 16:09
Excellent Sessions and Great Discussion

Related content which might interest you: Childhood interstitial lung disease: A diagnostic challenge Source: International Congress 2015 – Connective tissue disorders Year: 2015 Clinical highlights from the 2011 ERS Congress in Amsterdam Source: Eur Respir J 2012; 39: 1501-1510 Year: 2012 Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists? Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 A case series of eight patients treated with alectinib including a case of interstitial lung disease Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 COVID-19: Current Challenges in ILD Source: ERS webinar 2020: COVID-19: Current Challenges in ILD Year: 2020 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Clinical use of interstitial lung disease guidelines Source: Eur Respir Mon; 2009: 46: 386–395 Year: 2009 Development of the interstitial lung disease multidiciplinary team meeting 2005-2013 Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 ERS guidelines on treatment of sarcoidosis Source: ERS webinar 2021: ERS guidelines on treatment of sarcoidosis Year: 2021 The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Clues in interstitial lung disease in children (chILD) Source: International Congress 2016 – Paediatric bronchology II Year: 2016 Survival rates after a rehabilitation program in patients with interstitial lung disease Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions Year: 2014 Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases Source: International Congress 2016 – Orphan diseases II Year: 2016 B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015